- Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).
Annals of oncology : official journal of the European Society for Medical Oncology.
Times cited: 1
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.
Times cited: 1
- A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D. Gynecologic Oncology. 2017 Academic Article GET IT
- A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. 2017 Academic Article GET IT
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: An open-label, Single-arm, Phase 2 study. The Lancet. Oncology. 2013 Academic Article GET IT
A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study.
Cancer causes & control : CCC.
Times cited: 3